İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

SEYHAN ŞAHAN FIRAT

PROFESÖR

MERSİN ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmakoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 61
  • Proje 0
  • Kitap 2
  • Bildiri 89
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 2 Q2 13 Q3 2 Q4 3
WoS (JCR) Q1 2 Q2 2 Q3 12 Q4 6
TR Index 4 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 61 yayın

Makale listesi

  1. 2024 Protection by selective mTORC2 inhibition of Zymosan-induced hypotension and systemic inflammation mediated via IKKα/IκB-α/NF-κB activation Prostaglandins & Other Lipid Mediators DOI 10.1016/j.prostaglandins.2024.106918 YÖKSİS SJR Q2 JCR Q3
  2. 2024 mTORC2 inhibition by JR-AB2-011 improves IL-1β-induced inflammation, catabolic response, and apoptosis in human chondrocytes through IκB-α/NF-κB p65 Cellular and Molecular Biology DOI 10.14715/cmb/2024.70.9.5 YÖKSİS SJR Q4 JCR Q4
  3. 2023 NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IκB-α/NF-κB signaling pathway activity Cellular and Molecular Biology DOI 10.14715/cmb/2023.69.9.3 YÖKSİS SJR Q4 JCR Q4
  4. 2023 Pro-inflammatory GPR75 and anti-apoptotic phospholipase signaling pathways contribute to the ameliorating effect of soluble epoxide hydrolase inhibition on chronic experimental autoimmune encephalomyelitis in mice Cellular and Molecular Biology DOI 10.14715/cmb/2023.69.10.2 YÖKSİS SJR Q4 JCR Q4
  5. 2023 mTOR inhibition modulates apoptosis and oxidative stress in hindlimb ischemia/reperfusion injury Cukurova Medical Journal DOI https://dergipark.org.tr/tr/pub/cumj/issue/76401 YÖKSİS TR Index JCR Q3
  6. 2023 abc Glokom Katarakt YÖKSİS
  7. 2022 Bexarotene Ameliorates LPS-Induced Hyperalgesia: Contribution of TLR4/MyD88-Dependent Pro-Inflammatory, Anti-Apoptotic and Anti-Inflammatory Signaling Pathways International Journal of Pharmacology DOI 10.3923/ijp.2022.1171.1188 YÖKSİS SJR Q3 JCR Q4
  8. 2022 Pharmacological Inhibition of Mammalian Target of Rapamycin Attenuates Deoxycorticosterone Acetate Salt–Induced Hypertension and Related Pathophysiology: Regulation of Oxidative Stress, Inflammation, and Cardiovascular Hypertrophy in Male Rats Journal of Cardiovascular Pharmacology DOI 10.1097/FJC.0000000000001187 YÖKSİS SJR Q2 JCR Q3
  9. 2022 Activation of GPR75 Signaling Pathway Contributes to the Effect of a 20-HETE Mimetic, 5,14-HEDGE, to Prevent Hypotensive and Tachycardic Responses to Lipopolysaccharide in a Rat Model of Septic Shock JOURNAL OF CARDIOVASCULAR PHARMACOLOGY DOI 10.1097/FJC.0000000000001265 YÖKSİS SJR Q2 JCR Q3
  10. 2022 Inhibition of mTOR protects against skeletal muscle and kidney injury following hindlimb ischemia-reperfusion in rats by regulating MERK1/ERK1/2 activity. Cukurova Medical Journal DOI 10.17826/cumj.1021518 YÖKSİS TR Index JCR Q3
  11. 2021 Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model Neurochemical Research DOI 10.1007/s11064-020-03197-7 YÖKSİS SJR Q2 JCR Q2
  12. 2021 Involvement of Rho-kinase/IκB-α/NF-κB activation in IL-1β-induced inflammatory response and oxidative stress in human chondrocytes Canadian Journal of Physiology and Pharmacology DOI 10.1139/cjpp-2020-0305 YÖKSİS SJR Q2 JCR Q4
  13. 2021 mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats Canadian Journal of Physiology and Pharmacology DOI 10.1139/cjpp-2020-0487 YÖKSİS SJR Q2 JCR Q4
  14. 2021 Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl\u20103\u2010(1\u2010propionylpiperidin\u20104\u2010yl)urea prevents hyperalgesia through regulating\n NLRC4\n inflammasome\u2010related pro\u2010inflammatory and anti\u2010inflammatory signaling pathways in the lipopolysaccharide\u2010induced pain mouse model Drug Development Research DOI 10.1002/ddr.21786 YÖKSİS SJR Q3 JCR Q2
  15. 2020 Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner. INFLAMMOPHARMACOLOGY YÖKSİS SJR Q2 JCR Q1
  16. 2019 Eicosanoids derived from cytochrome P450 pathway of arachidonic acid and inflammatory shock. PROSTAGLANDINS OTHER LIPID MEDIATORS YÖKSİS SJR Q2 JCR Q3
  17. 2019 Targeting mTOR: up-to-date mTOR inhibitors. Bioorganic Medicinal Chemistry Reports YÖKSİS
  18. 2019 Modulation of oxidative/nitrosative stress and inflammatory response by rapamycin in target and distant organs in rats exposed to hindlimb ischemia/reperfusion: The role of mTOR. Canadian Journal of Physiology and Pharmacology YÖKSİS SJR Q2 JCR Q3
  19. 2019 NF-κB activation mediates LPS- or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY YÖKSİS SJR Q2 JCR Q3
  20. 2019 Polyphenols and targets in age-related disorders; mTOR signalling pathway Mersin Üniversitesi Sağlık Bilimleri Dergisi DOI 10.26559/mersinsbd.630237 YÖKSİS TR Index

Akademisyenlere dön